Samil Pharmaceutical's Largest Shareholder Family Slightly Increases Stake to 25.93% via Open Market Purchase… Controlling Stability Maintained, Minimal Impact on Shareholder Value
Filing of change in ownership by largest shareholder: The combined stake of the largest shareholder Heo Seung-beom and 13 related parties increased from 25.90% to 25.93% (net purchase of 6,939 shares) between May 22 and June 2, 2026
Reason for change: Heo Yul and Heo Yi-jeong, family members, each purchased 3,491 and 3,448 shares on the open market, slightly increasing their holdings
This stake change is minor (approx. KRW 51.5 million) and has limited impact on management control; no direct effect on shareholder value
[AI Summary]This disclosure is a routine report of a slight increase in stake by the largest shareholder's family through small open-market purchases, judged to be a neutral event with no material impact on enterprise or shareholder value
KOSPI Filing Information
Filing: Report on Change in Ownership of Major Shareholders, etc.